5 Things Pharmacy Leaders Should Learn
By Joel Wright, President of Pharmacy Services, VytlOne
Artificial intelligence (AI) is moving from pilot projects into the core of pharmacy operations. In health system pharmacy and 340B programs, that shift carries more weight than almost anywhere else, because here AI touches patient access, compliance risk, and the use of limited resources across vulnerable populations.
After working inside these programs, the lesson I keep returning to is simple. The value of AI is not decided by how advanced it is. It is decided by how thoughtfully it is governed and how closely it stays tied to patient outcomes.
Here are five things every pharmacy leader should learn before adopting it.
1. AI in pharmacy is a governance decision, not a technology purchase
Most technology decisions reside within IT. AI in a health system-owned pharmacy extends far beyond technology, enabling smarter patient outreach, more effective resource allocation, and greater visibility into 340B opportunities. As AI becomes a strategic driver of outcomes, governance is what makes sure that innovation is applied responsibly and consistently.
Effective governance includes:
- Clear accountability for AI-enabled decision support.
- Oversight of any model that influences outreach or prioritization.
- Continuous monitoring for differential effects across patient populations and payer types.
- Transparency about how recommendations are generated.
- The ability for pharmacists and clinicians to override automated guidance.
Before you evaluate a single feature, answer one question. When AI influences a decision, who is accountable for it?
2. Responsible AI should reduce bias and widen access, not narrow it
AI has the power to enhance decision-making and operational performance. With the right governance and design principles, organizations can proactively address potential biases and support more consistent outcomes.
Designed responsibly, AI does the opposite of what people fear. By expanding the data signals it considers, incorporating human oversight, and regularly testing for unintended disparities, it can surface patients who might otherwise be missed, including those who are newly diagnosed or facing barriers like affordability and access. In a pharmacy that sits inside the clinical care continuum, that capability lets an organization extend access more intentionally and strengthen patient trust.
3. The point of AI is action, not better reports
Traditional pharmacy analytics are good at explaining what already happened. Revenue and cost trends, capture rates, adherence percentages. What reporting rarely tells a team is what to do next.
For AI to change that, it has to be grounded in a holistic data strategy. Most of the data that supports pharmacy decisions is scattered across clinical systems, pharmacy platforms, payer feeds, and financial tools, or never captured at all. Connecting those sources, and delivering insight in time to influence care, is the foundation.
The next evolution of pharmacy intelligence surfaces issues while prescriptions and referrals are still upstream, prioritizes intervention based on clinical and operational context, and routes work to the right team members. That move from hindsight to insight is where AI starts to earn its place.
4. Human review is the most important design point
The most important design point in any responsible system is human review. AI can surface insights and opportunities, but clinicians and pharmacy teams remain responsible for every care and operational decision.
Pharmacists and clinicians need a real ability to override automated recommendations, not a checkbox that exists on paper. That is what keeps AI aligned with pharmacy operations, 340B requirements, and patient safety, while still accelerating the work.
5. Where your AI comes from matters
As adoption accelerates, the source of the intelligence matters as much as the intelligence itself. Many of the solutions entering the market today are built by strong engineering teams with no pharmacists, no 340B compliance depth, and no history operating inside the complexity of a health system.
The foundation needs to be built and validated by pharmacists and operators who have actually worked inside the systems the technology intends to serve.
That is the thinking behind VytlAIQ, our AI enabled pharmacy intelligence platform built specifically for health system environments. It is designed around continuous 340B eligibility review, real time performance visibility across pharmacy operations, workflow automation, and next best action guidance to support clinical decision making. The point is not the feature list. The point is that responsible AI shows up as integrated workflows and data models aligned with compliance, care delivery, and equity goals.
Looking ahead: responsible AI and sustainable 340B performance
AI has real potential to help health system pharmacies navigate the growing complexity of 340B, specialty pharmacy, and access management. Its value will not be determined by sophistication alone. It will be determined by how thoughtfully it is governed, how transparently it operates, and how closely it remains tied to patient outcomes.
For organizations willing to lead with accountability and clinical oversight, AI becomes a tool that supports sustainable 340B performance while advancing the core mission of equitable, high-quality care.
See how VytlAIQ approaches responsible AI for health system pharmacy. Request a demo.
Joel Wright is President of Pharmacy Services at VytlOne. He can be reached at [email protected].